Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Vertex Pharmaceuticals: Hochstufung

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Evercore ISI stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807,…

Vertex Pharmaceuticals: Kursziel gesteigert

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von H.C. Wainwright & Co. bewerten die Aktie des US-Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN:…

Could This Stock Be the Next Biotech Buyout? @themotleyfool #stocks $VERA $VRTX $ALPN

Vertex Pharmaceuticals $4.9 billion purchase of Alpine Immune Sciences probably wont be the last acquisition of a company focused on…

Could This Stock Be the Next Biotech Buyout?

Vertex Pharmaceuticals $4.9 billion purchase of Alpine Immune Sciences probably wont be the last acquisition of a company focused on…

Vertex Pharmaceuticals: Alpine Accelerates Aspiration To Become Biotech Powerhouse

…

What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences

…

Jim Cramer shares his thoughts on Nike, Vertex Pharmaceuticals, CarMax, Airbnb, Visa and Mastercard

During the CNBC Investing Clubs Morning Meeting, Jim Cramer weighed in on the stock moves in Nike, Vertex Pharma and…

Vertex Pharmaceuticals: Buy, Sell, or Hold?

The stock hasnt made for a great buy this year, but is Vertex worth investing in for the long run?…

Vertex Pharmaceuticals: Buy, Sell, or Hold? @themotleyfool #stocks $VRTX

The stock hasnt made for a great buy this year, but is Vertex worth investing in for the long run?…

Vertex Pharmaceuticals: Übernahme von Alpine Immune Sciences - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Vertex Pharmaceuticals Inc.…

Milliarden-Deal! Ausgerechnet Vertex schlägt zu

Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…

Milliarden-Deal! Ausgerechnet Vertex schlägt zu

Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

…

Übernahme: Vertex Pharmaceuticals erwirbt Alpine Immune für Milliardensumme

Das biopharmazeutische Unternehmen will die Biotechfirma für rund 4,9 Milliarden Dollar übernehmen. Die Aktien von Alpine legten nachbörslich 36 Prozent…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion

With the acquisition, Vertex will add Alpines portfolio of protein-based immunotherapies to treat autoimmune and inflammatory diseases.…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion By Reuters

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln

Vertex Pharmaceuticals will acquire therapy developer Alpine Immune Sciences for $65 per share, or about $4.9 billion in cash, the…

Biotech Stocks: 5 Biggest Companies in 2024

What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in…

Vertex Pharmaceuticals: Ein führender Schmerzmediziner "bemerkenswert negativ" zu VX-548 - Aktienanalyse

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Die Analysten vom Investmenthaus RBC Capital Markets trauen der Aktie von Vertex…

Vertex Pharmaceuticals executive sells shares worth over $100k By Investing.com

Vertex Pharmaceuticals executive sells shares worth over $100k…

Vertex (VRTX) Continues to Diversify Beyond CF Franchise

While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of…

Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development

Vertex Pharmaceuticals (VRTX) plans to begin a phase I study on VX-407 in autosomal dominant polycystic kidney disease later this…

Vertex Pharmaceuticals: Diversifying Its Drug Portfolio For Future Growth

…

Forget Tesla, Buy This Magnificent Healthcare Stock Instead

Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.…

5 Small Biotech ETFs to Watch (Updated 2024)

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX $CRSP

Vertex shares have climbed almost 50% over the past year.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex shares have climbed almost 50% over the past year.…

The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies

JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies are part of the Zacks top Analyst Blog.…

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market

Vertexs main business may be heading for a new era of growth...…

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market @themotleyfool #stocks $VRTX

Vertexs main business may be heading for a new era of growth...…

Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Heres Why Thats a Smart Move.

…

Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Heres Why Thats a Smart Move.

Sometimes, the winning move doesnt look right at first.…

Stock-Split Watch: Is Vertex Pharmaceuticals Next? @themotleyfool #stocks $VRTX

Its on track to launch more blockbuster drugs.…

Stock-Split Watch: Is Vertex Pharmaceuticals Next?

Its on track to launch more blockbuster drugs.…

If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today

You cant go back in the past, but its not too late to invest in this top stock.…

New CRISPR Gene-Editing Treatment Approved In Europe For Inherited Blood Disorders

The decision comes after Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy was approved in the UK and US for sickle cell…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Is Vertex Pharmaceuticals Stock a Buy Now? @themotleyfool #stocks $VRTX

The company just released its latest earnings report, and growth investors may be a little disappointed.…

Is Vertex Pharmaceuticals Stock a Buy Now?

The company just released its latest earnings report, and growth investors may be a little disappointed.…

Could Vertex Pharmaceuticals Reach $500 in 2024? @themotleyfool #stocks $VRTX

Vertex shares have several catalysts on the horizon...…

Could Vertex Pharmaceuticals Reach $500 in 2024?

Vertex shares have several catalysts on the horizon...…

Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Heres How You Can Invest

Its foray into developing analgesics seems to be going swimmingly.…

Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Heres How You Can Invest @themotleyfool #stocks $VRTX

Its foray into developing analgesics seems to be going swimmingly.…

Futures Dip; Palantir Soars On Surging AI Demand

Other key earnings movers include Eli Lilly, Spotify and Vertex Pharmaceuticals.…

Vertex Pharmaceuticals: Gute Q4-Zahlen - Das nächste Mukoviszidose-Mittel steht in den Startlöchern - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript

VRTX earnings call for the period ending December 31, 2023.…

Vertex Pharmaceuticals Incorporated 2023 Q4 - Results - Earnings Call Presentation

…

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy? @themotleyfool #stocks $VRTX

Vertex shares recently reached an all-time high.…

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?

Vertex shares recently reached an all-time high.…

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?

…